SureTrader Nadex Advertisement PGUS
Home > Boards > US OTC > Biotechs > PharmaCyte Biotech Inc. (PMCB)

NVLX

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
NYC Trader Member Profile
 
Followed By 1,090
Posts 143,448
Boards Moderated 5
Alias Born 01/25/09
160x600 placeholder
PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing "GlobeNewswire Inc." - 3/22/2017 9:20:00 AM
PharmaCyte Biotech CEO Addresses IND Submission Questions "GlobeNewswire Inc." - 3/17/2017 9:00:00 AM
PharmaCyte Biotech Names Dr. Leonard Makowka as Senior Strategic Advisor "GlobeNewswire Inc." - 3/13/2017 9:00:00 AM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 3/13/2017 8:40:20 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 3/13/2017 8:04:14 AM
First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals "Marketwired" - 2/23/2017 9:15:00 AM
PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial "GlobeNewswire Inc." - 2/21/2017 9:25:00 AM
PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal... "GlobeNewswire Inc." - 2/13/2017 9:00:00 AM
PharmaCyte Biotech Releases Shareholder Call and Complete Q&A Playback Information "GlobeNewswire Inc." - 2/8/2017 9:00:00 AM
PharmaCyte Biotech Provides Update for February 7th Shareholder Call "GlobeNewswire Inc." - 2/2/2017 9:00:00 AM
PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA "GlobeNewswire Inc." - 1/30/2017 9:00:00 AM
PharmaCyte Going Head to Head with Eli Lilly's Pancreatic Cancer Drug in New Clinical Trial "Marketwired" - 1/24/2017 9:10:00 AM
PharmaCyte Biotech to Hold Shareholder Call "GlobeNewswire Inc." - 1/18/2017 9:00:00 AM
PharmaCyte Biotech Discusses Upcoming Clinical Trial with Principal Investigator Dr. Manuel Hidalgo "GlobeNewswire Inc." - 1/10/2017 9:10:00 AM
PharmaCyte Biotech Announces Pre-IND Meeting Date with FDA "GlobeNewswire Inc." - 1/4/2017 9:25:00 AM
PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers "GlobeNewswire Inc." - 12/27/2016 9:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/21/2016 6:05:44 AM
PharmaCyte Biotech Submits Pre-IND Meeting Package to FDA "GlobeNewswire Inc." - 12/15/2016 9:47:16 AM
Traders News Issues New Reports and Features a New OTCQB Company Profile "InvestorsHub NewsWire" - 12/13/2016 9:25:00 AM
PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial "Marketwired" - 12/12/2016 9:00:00 AM
PharmaCyte Biotech Discusses Upcoming Clinical Trial in Pancreatic Cancer with First Principal Investigator "GlobeNewswire Inc." - 12/7/2016 9:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 12/2/2016 5:29:05 PM
PharmaCyte Biotech Moves Closer to Enrolling Patients in Pancreatic Cancer Clinical Trial "Marketwired" - 12/1/2016 9:00:00 AM
PharmaCyte Biotech Granted FDA Pre-IND Meeting for Pancreatic Cancer Therapy "GlobeNewswire Inc." - 11/29/2016 9:00:00 AM
PharmaCyte Biotech Now Awaits U.S. FDA to Advance Pancreatic Cancer Therapy into Pivotal Clinical Trial "Marketwired" - 11/16/2016 9:15:00 AM
NYC Trader   Friday, 05/10/13 07:49:08 AM
Re: None
Post # of 66217 
NVLX
Link: http://www.otcmarkets.com/stock/NVLX/company-info
Ticker: $NVLX
OTC Market Tier: OTCQB
CIK code: 0001157075
Company name: Nuvilex, Inc.
Company website: http://www.nuvilex.com
Incorporated In: NV, USA



Visit my board"NY Penny Stock Exchange" for today's pick at http://investorshub.advfn.com/boards/board.aspx?board_id=16752
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist